Vincristine sulfate and Neurological decompensation - a phase IV clinical study of FDA data

Summary:

Neurological decompensation is reported as a side effect among people who take Vincristine sulfate (vincristine sulfate), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Morphine, and have High blood pressure.

The phase IV clinical study analyzes which people have Neurological decompensation when taking Vincristine sulfate. It is created by eHealthMe based on reports of 30,476 people who have side effects when taking Vincristine sulfate from the FDA, and is updated regularly.

What is Vincristine sulfate?

Vincristine sulfate has active ingredients of vincristine sulfate. It is often used in non-hodgkin's lymphoma. eHealthMe is studying from 30,518 Vincristine sulfate users. Check the latest studies of Vincristine sulfate.

What is Neurological decompensation?

Neurological decompensation (inability of brain to maintain proper function) is found to be associated with 264 drugs and 451 conditions by eHealthMe. Check the latest studies of Neurological decompensation.

On Jul, 15, 2026

30,476 people reported to have side effects when taking Vincristine sulfate.
Among them, 28 people (0.09%) have Neurological decompensation.

Could Vincristine sulfate cause Neurological decompensation?

Among these 28 people:

How long have people been on Vincristine sulfate when they have Neurological decompensation? *

What is the gender of people who have Neurological decompensation when taking Vincristine sulfate? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Neurological decompensation when taking Vincristine sulfate? *

What are other drugs people take besides Vincristine sulfate? *

What are other side effects people have besides Neurological decompensation? *

Fever: 14 people, 50.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 13 people, 46.43%
Arrhythmias (irregular heartbeat): 12 people, 42.86%
Loss Of Consciousness: 12 people, 42.86%
Headache (pain in head): 12 people, 42.86%
Nausea And Vomiting: 12 people, 42.86%
Inflammation: 12 people, 42.86%
Weight Loss: 11 people, 39.29%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 11 people, 39.29%
Muscle Aches (muscle pain): 11 people, 39.29%

What are the existing conditions these people have? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 12 people, 42.86%
High Blood Pressure: 12 people, 42.86%
Hodgkin's Lymphoma (cancer originating from white blood cells): 11 people, 39.29%
Pain: 7 people, 25.00%
Pneumonia: 6 people, 21.43%
Pain In Extremity: 6 people, 21.43%
Back Pain: 6 people, 21.43%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 2 people, 7.14%
Venous Thrombosis (blood clot (thrombus) that forms within a vein): 1 person, 3.57%
Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Vincristine sulfate and have Neurological decompensation?

- Check whether Neurological decompensation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vincristine sulfate:

Vincristine sulfate (30,518 reports)

Browse all side effects of Vincristine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neurological decompensation:

Neurological decompensation (264 drugs)

Browse all the conditions that are associated with Neurological decompensation:

Neurological decompensation (451 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vincristine sulfate (the active ingredients of Vincristine sulfate) and Vincristine sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.